X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5059) 5059
Book Review (557) 557
Publication (189) 189
Newsletter (48) 48
Newspaper Article (19) 19
Magazine Article (15) 15
Conference Proceeding (10) 10
Book Chapter (8) 8
Dissertation (4) 4
Trade Publication Article (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4005) 4005
humans (3199) 3199
diclofenac (2560) 2560
male (2097) 2097
female (2054) 2054
diclofenac - adverse effects (1532) 1532
middle aged (1390) 1390
anti-inflammatory agents, non-steroidal - adverse effects (1347) 1347
adult (1338) 1338
aged (1063) 1063
diclofenac - administration & dosage (1063) 1063
diclofenac - therapeutic use (1047) 1047
anti-inflammatory agents, non-steroidal - administration & dosage (975) 975
anti-inflammatory agents, non-steroidal - therapeutic use (937) 937
pharmacology & pharmacy (929) 929
nonsteroidal antiinflammatory drugs (889) 889
animals (871) 871
nonsteroidal anti-inflammatory drugs (835) 835
double-blind method (768) 768
pain (610) 610
treatment outcome (572) 572
surgery (442) 442
osteoarthritis (439) 439
drugs (435) 435
pain measurement (428) 428
analysis (425) 425
rats (422) 422
diclofenac sodium (394) 394
double-blind (384) 384
abridged index medicus (383) 383
prospective studies (377) 377
adolescent (363) 363
medicine, general & internal (354) 354
aged, 80 and over (338) 338
ibuprofen (333) 333
diclofenac - pharmacology (331) 331
care and treatment (327) 327
efficacy (312) 312
pain, postoperative - drug therapy (312) 312
celecoxib (310) 310
environmental sciences (307) 307
medicine & public health (307) 307
inflammation (302) 302
risk factors (302) 302
analgesics (291) 291
pharmaceuticals (290) 290
rheumatoid-arthritis (288) 288
dose-response relationship, drug (284) 284
nsaids (281) 281
time factors (277) 277
osteoarthritis - drug therapy (274) 274
sodium (270) 270
anesthesiology (263) 263
administration, oral (262) 262
diclofenac - analogs & derivatives (255) 255
indomethacin (255) 255
toxicology (254) 254
anti-inflammatory agents, non-steroidal - pharmacology (250) 250
administration, topical (249) 249
drug therapy (249) 249
ophthalmology (249) 249
drug therapy, combination (245) 245
gastroenterology & hepatology (240) 240
research (236) 236
naproxen (235) 235
analgesia (229) 229
pain - drug therapy (220) 220
management (217) 217
diclofenac - pharmacokinetics (216) 216
rheumatology (210) 210
young adult (210) 210
safety (207) 207
dosage and administration (204) 204
pharmacology/toxicology (203) 203
risk (203) 203
toxicity (201) 201
nsaid (200) 200
clinical trials (199) 199
arthritis (196) 196
arthritis, rheumatoid - drug therapy (193) 193
diclofenac - chemistry (188) 188
mice (188) 188
pharmacokinetics (182) 182
rats, wistar (182) 182
anti-inflammatory agents, non-steroidal - pharmacokinetics (181) 181
pain, postoperative - prevention & control (176) 176
postoperative pain (171) 171
acetaminophen (167) 167
internal medicine (167) 167
medicine, research & experimental (166) 166
randomized controlled trials as topic (166) 166
aspirin (163) 163
diclofenac - toxicity (160) 160
cox-2 inhibitors (159) 159
cyclooxygenase inhibitors - adverse effects (157) 157
follow-up studies (156) 156
ketorolac (156) 156
administration, cutaneous (152) 152
complications and side effects (152) 152
drug administration schedule (151) 151
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4779) 4779
German (129) 129
French (55) 55
Spanish (49) 49
Russian (31) 31
Japanese (20) 20
Italian (16) 16
Chinese (10) 10
Dutch (9) 9
Polish (7) 7
Swedish (7) 7
Danish (5) 5
Hungarian (5) 5
Hebrew (4) 4
Korean (4) 4
Portuguese (4) 4
Croatian (3) 3
Persian (3) 3
Turkish (3) 3
Bulgarian (2) 2
Ukrainian (2) 2
Malay (1) 1
Norwegian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Baigent, Colin and Bhala, N and Emberson, J and Merhi, A and Abramson, S and Arber, N and Baron, J.A and Bombardier, C and Cannon, C and Farkouh, M.E and FitzGerald, G.A and Goss, P and Halls, H and Hawk, E and Hawkey, C and Hennekens, C and Hochberg, M and Holland, L.E and Kearney, P.M and Laine, L and Lanas, A and Lance, P and Laupacis, A and Oates, J and Patrono, C and Schnitzer, T.J and Solomon, S and Tugwell, P and Wilson, K and Wittes, J and Adelowo, O and Aisen, P and Al-Quorain, A and Altman, R and Bakris, G and Baumgartner, H and Bresee, C and Carducci, M and Chang, D.-M and Chou, C.-T and Clegg, D and Cudkowicz, M and Doody, L and Miedany, Y.El and Falandry, C and Farley, J and Ford, L and Garcia-Losa, M and Gonzalez-Ortiz, M and Haghighi, M and Hala, M and Iwama, T and Jajic, Z and Kerr, D and Kim, H.-S and Kohne, C and Koo, B.-K and Martin, B and Meinert, C and Muller, N and Myklebust, G and Neustadt, D and Omdal, R and Ozgocmen, S and Papas, A and Patrignani, P and Pelliccia, F and Roy, V and Schlegelmilch, I and Umar, A and Wahlstrom, O and Wollheim, F and Yocum, S and Zhang, X.Y and Hall, E and McGettigan, P and Midgley, R and Moore, R.A and Philipson, R and Curtis, S and Reicin, A and Bond, J and Moore, A and Essex, M and Fabule, J and Morrison, B and Tive, L and Bhala, N and Davies, K and Emberson, J and Halls, H and Holland, L.E and Kearney, P.M and Merhi, A and Patrono, C and Wilson, K and Yau, F and Coxib Traditional NSAID Trialists and Coxib and traditional NSAID Trialists' (CNT) Collaboration
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9894, pp. 769 - 779
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 06/2006, Volume 113, Issue 25, pp. 2906 - 2913
Background-The selective cyclooxygenase-2 (COX-2) inhibitors and other nonselective nonsteroidal antiinflammatory drugs ( NSAIDs) have been associated with... 
Drugs | Myocardial infarction | Cyclooxygenase-2 inhibitors | Mortality | Nonsteroidal antiinflammatory drugs | RHEUMATOID-ARTHRITIS | POPULATION | CARDIAC & CARDIOVASCULAR SYSTEMS | drugs | CARDIOVASCULAR EVENTS | myocardial infarction | CONVERTING ENZYME-INHIBITORS | RANDOMIZED CONTROLLED-TRIAL | CELECOXIB | BLOOD-PRESSURE | nonsteroidal antiinflammatory drugs | mortality | CYCLO-OXYGENASE-2 INHIBITORS | ROFECOXIB | PERIPHERAL VASCULAR DISEASE | BETA-BLOCKERS | HEMATOLOGY | cyclooxygenase-2 inhibitors | Ibuprofen - therapeutic use | Multivariate Analysis | Recurrence | Sulfones - therapeutic use | Confidence Intervals | Myocardial Infarction - mortality | Pyrazoles - therapeutic use | Patient Readmission | Humans | Middle Aged | Sulfones - adverse effects | Male | Dose-Response Relationship, Drug | Cyclooxygenase 2 Inhibitors - adverse effects | Cyclooxygenase 2 Inhibitors - therapeutic use | Aged, 80 and over | Female | Registries | Retrospective Studies | Odds Ratio | Pyrazoles - adverse effects | Diclofenac - therapeutic use | Diclofenac - adverse effects | Risk Factors | Proportional Hazards Models | Celecoxib | Lactones - adverse effects | Lactones - therapeutic use | Cross-Over Studies | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Myocardial Infarction - drug therapy | Sulfonamides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Denmark | Sulfonamides - adverse effects | Aged | Ibuprofen - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 01/2017, Volume 166, Issue 1, pp. 58 - 68
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9736, pp. 173 - 179
Summary Background Cyclo-oxygenase (COX)-2-selective non-steroidal anti-inflammatory drugs (NSAIDs) and non-selective NSAIDs plus a proton-pump inhibitor (PPI)... 
Internal Medicine | GASTROINTESTINAL TOXICITY | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | MUCOSAL INJURY | OARSI RECOMMENDATIONS | RISK | NAPROXEN | PLUS OMEPRAZOLE | KNEE OSTEOARTHRITIS | EVIDENCE-BASED RECOMMENDATIONS | Lower Gastrointestinal Tract - drug effects | Osteoarthritis - ethnology | Humans | Middle Aged | Peptic Ulcer - prevention & control | Male | Osteoarthritis - drug therapy | Cyclooxygenase 2 Inhibitors - adverse effects | Arthritis, Rheumatoid - drug therapy | Adult | Female | Drug Therapy, Combination | Pyrazoles - adverse effects | Anti-Ulcer Agents - therapeutic use | Omeprazole - therapeutic use | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Diclofenac - adverse effects | Risk Factors | Treatment Outcome | Celecoxib | Pyrazoles - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Upper Gastrointestinal Tract - drug effects | Arthritis, Rheumatoid - ethnology | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Sulfonamides - adverse effects | Diclofenac - administration & dosage | Peptic Ulcer - chemically induced | Research Design | Sulfonamides - administration & dosage | Omeprazole | Rheumatoid arthritis | Dosage and administration | Research | Comparative analysis | Drug therapy | Diclofenac | Heart failure | Likert scale | Inflammatory bowel disease | Arthritis | Clinical medicine | Index Medicus | Abridged Index Medicus
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2006, Volume 4, Issue 2, pp. 196 - 202
Journal Article
The Lancet, ISSN 0140-6736, 2004, Volume 364, Issue 9435, pp. 675 - 684
Journal Article